April 24, 2014
VICC debuts novel neuroendocrine tumor treatment
A retired elementary school principal has become the first patient at Vanderbilt-Ingram Cancer Center to receive an investigational cancer therapy for the treatment of his neuroendocrine tumor.
By VUMC News and Communications